Strategic Acquisition CRYOPDP is now part of DHL Health Logistics after a 2025 acquisition, presenting an opportunity to leverage DHL’s broader customer base and global network for cross-sell of temperature-controlled life sciences logistics and expanded service offerings.

Blockchain Leadership Recent recognition for a privacy-enabled blockchain platform in healthcare logistics positions CRYOPDP as a tech-forward partner; sales teams can target pharma and biotech customers seeking compliant, transparent cold chain traceability and data integrity.

Global Reach Operates in over 150 countries with a dedicated life sciences focus; potential upsell to multinational biopharma and cell & gene therapy programs requiring global, temperature-controlled shipping and storage solutions.

Rapid Growth Signals Expansion milestones include new Chicago facility and ongoing collaborations; these advances signal capacity growth and readiness to handle larger or more complex clinical trials and CGT shipments.

Awarded & Trusted Industry awards for digital transformation and achievements in life sciences logistics enhance credibility; use these accolades to accelerate partnerships with risk-averse customers prioritizing compliance, efficiency, and reliability.